I think saying SUN S.P. is dependent on special divvy is very narrow call. It has a nice safe divvy level already: each of 4 brokers I've reviewed since Motley/OM call have ranked SUN as best bet in the insurance sector going into lower AUD and RBA interest prediction. So a special divvy would thrust it up, without special divvy I think it will see into's/SMSFs investing as a "defensive growth" (sorry about teh oxymoron) stock in coming 6 months.
QBE is 40% Brexit exposed - it's virtually a spec stock until everyone knows Brexit/Banking/employment in UK.
Whereas SUN has '17 growth predictions and only local exposure, so US dollar/Brexit risk factors greatly reduced from IAG/QBE risks will amke it very attractive to medium/long hedge investors (yes I know, despite its insurance industry risk).
Either of us could be wrong JC, but if I'm wrong I'm wrong along with 5 brokers/analysts.
Nothing personal JC, I just bit at your introduction to your statement "no..." which is kinda patronising while your pumping another stock.
- Forums
- ASX - By Stock
- SUN
- SUN - Time to Buy??
SUN - Time to Buy??, page-67
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SUN (ASX) to my watchlist
|
|||||
Last
$17.07 |
Change
0.090(0.53%) |
Mkt cap ! $21.60B |
Open | High | Low | Value | Volume |
$17.01 | $17.09 | $17.01 | $2.949M | 173.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 3263 | $17.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.08 | 3567 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 3325 | 17.070 |
18 | 3067 | 17.060 |
9 | 1894 | 17.050 |
10 | 2697 | 17.040 |
10 | 2121 | 17.030 |
Price($) | Vol. | No. |
---|---|---|
17.080 | 39 | 3 |
17.090 | 4788 | 11 |
17.100 | 3399 | 11 |
17.110 | 2915 | 9 |
17.120 | 2872 | 8 |
Last trade - 10.30am 16/07/2024 (20 minute delay) ? |
Featured News
SUN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online